Journal article
Epigenetic regulation of inflammation by dopamine in primary human macrophages
Frontiers in immunology, v 17, 1779072
01 Jun 2026
PMID: 42433357
Abstract
IntroductionWhile dopamine is a monoamine neurotransmitter best known for its roles in reward, motivation, and motor function in the central nervous system, its actions extend beyond neurons and can influence non-neuronal cells via epigenetic mechanisms. An increasing body of literature demonstrates that dopamine signaling is important in immune cells, which express dopamine receptors (DRD1-DRD5) as well as the molecular machinery for dopamine synthesis and metabolism. Dopamine can regulate inflammatory activity, cell trafficking, and disease pathology, yet the epigenetic mechanisms underlying these effects remain poorly understood.MethodsPrimary human monocyte-derived macrophages were treated with dopamine, and DNA methylation at the IL-1β proximal promoter was evaluated alongside IL-1β and epigenetic enzyme gene expression. Associations between donor characteristics, dopamine receptor expression, and dopamine-induced epigenetic responses were also examined.ResultsDopamine increased DNA methylation at the IL-1β proximal promoter in a DNMT-dependent manner while concurrently increasing IL-1β gene expression. Dopamine treatment also upregulated the expression of several key epigenetic regulators, including TET2, HDAC2, and HDAC6, suggesting coordinated regulation of both DNA methylation and histone modifications that shape inflammatory transcription. Furthermore, baseline dopamine receptor expression and donor demographics, including sex and age, influence the magnitude of these epigenetic responses, highlighting inter-individual variability in macrophage sensitivity to dopaminergic signaling.DiscussionThese findings establish dopamine as a modulator of macrophage inflammation via epigenetic remodeling and provide a mechanistic framework for understanding how peripheral immune cells respond to dopaminergic cues. By linking dopamine signaling, epigenetic regulation, and innate immunity, this work identifies potential targets for therapeutic intervention and supports the use of accessible human immune cells to investigate dopaminergic dysregulation in neuroimmunological disorders.
Metrics
1 Record Views
Details
- Title
- Epigenetic regulation of inflammation by dopamine in primary human macrophages
- Creators
- Yash Agarwal - Drexel UniversityYash Agarwal - Drexel UniversityMargish Ramani - Drexel UniversitySamyuktha Manikandan - Drexel UniversityKimberly Bonar - Drexel UniversityJohn Montilla Luna - Drexel UniversityPeter J. Gaskill - Drexel UniversityStephanie M. Matt - Drexel University
- Publication Details
- Frontiers in immunology, v 17, 1779072
- Publisher
- Frontiers Media S.A
- Number of pages
- 18
- Grant note
- National Institutes of Health: DA039005, DA057337, DA058051, DA049227, MH132466 W.W. Smith Charitable Trust Foundation: A2003 Brody Family Medical Trust Fund (SMM) Cotswold Foundation Fellowship Department of Pharmacology and Physiology at Drexel University College of Medicine
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by grants from the National Institutes of Health, DA039005, DA057337, DA058051 and DA049227 (PG), MH132466 (SMM), as well as the W.W. Smith Charitable Trust Foundation Grant A2003 (PG), the Brody Family Medical Trust Fund (SMM), the Cotswold Foundation Fellowship (SMM), and the Department of Pharmacology and Physiology at Drexel University College of Medicine.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine; Pharmacology and Physiology; General Internal Medicine
- Web of Science ID
- WOS:001815489500001
- Other Identifier
- 991022193894504721